Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

Piteau, Shalea, Olver, Amy, Kim, Su-Jin, Winter, Kyle, Pospisilik, John Andrew, Lynn, Francis, Manhart, Susanne, Demuth, Hans-Ulrich +3 more·2007·Biochemical and Biophysical Research Communications

Cited by (130)

Items 101–130 of 130

  1. Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats
    Nigel Irwin, Jacqueline M. E. Francis, Peter R. Flatt · 2011 · Biological Chemistry
  2. Secretagogin Is Highly Expressed in Enteroendocrine K Cells and Plays a Critical Role in Nutrient-Induced GIP Secretion
    Xinyu Liu, Xuan Liu, Yuanyuan Hu, Xin Wang, Xin Yang, Yan Bin, Yi Zhou, Lingzhi Zhou, Gang Fan, Jing Yang · 2025 · Journal of the Endocrine Society
  3. Molecular Characterization of Grass Carp GIPR and Effect of Nutrition States, Insulin, and Glucagon on Its Expression
    Guokun Yang, Xiaomin Liang, Yanle Jiang, Chengquan Li, Yanmin Zhang, Xindang Zhang, Xulu Chang, Yawei Shen, Xiaolin Meng · 2022 · Aquaculture Nutrition
  4. Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes
    Karlijn A. C. Meeks, Amy R. Bentley, Themistocles L. Assimes, Nora Franceschini, Adebowale Adeyemo, Charles N. Rotimi, Ayo Priscille Doumatey · 2023 · Genome Medicine
  5. Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15
    Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, Giorgio Luciano Viviani · 2015 · Journal of Diabetes Research
  6. Innovative Glucagon-based Therapies for Obesity
    Kibret Enyew Belay, Rebil Heiru Jemal, Aloys Tuyizere · 2024 · Journal of the Endocrine Society
  7. Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion
    Gonzalo-Martín Pérez-Arana, Alfredo Díaz-Gómez, Alonso Camacho-Ramírez, Antonio Ribelles-García, David Almorza Gomar, Manuel Ángel Gracia Romero, Isabel Mateo-Gavira, Maria Jesús Castro Santiago, Juan Casar-García, José Arturo Prada Oliveira · 2023 · Annals of Anatomy - Anatomischer Anzeiger
  8. The role of glucagon after bariatric/metabolic surgery: much more than an “anti-insulin” hormone
    Gonzalo-Martín Pérez-Arana, Alfredo Díaz-Gómez, José Bancalero-De Los Reyes, Manuel Ángel Gracia Romero, Antonio Ribelles-García, Francisco Visiedo, Álvaro González‐Domínguez, David Almorza Gomar, José Arturo Prada Oliveira · 2023 · Frontiers in Endocrinology
  9. Polypharmacology in Clinical Applications: Metabolic Disease Polypharmacology
    Zhiguo Wang, Baofeng Yang · 2022 · Springer eBooks
  10. Dipeptidyl Peptidase IV Inhibitors for Treatment of Diabetes
    Christopher H.S. McIntosh, S.‐J. Kim, Raymond A. Pederson, Ulrich F. Heiser, Hans‐Ulrich Demuth · 2011 · Wiley eBooks
  11. GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide
    Tae Jung Oh · 2024 · Journal of Korean Diabetes
  12. Long-term levels of bile acids, fibroblast growth factor-19, and glucagon-like peptide-1 after bariatric surgery
    Mee Kyoung Kim, Hyuk‐Sang Kwon, Ki‐Hyun Baek, Ki‐Ho Song · 2024 · Asian Journal of Surgery
  13. Dietary Vitamin A Affects the Function of Incretin-Producing Enteroendocrine Cells in Male Mice Fed a High-Fat Diet
    Rossana M. Calderon, Marcin Golczak, Jisun Paik, William S. Blaner · 2023 · Journal of Nutrition
  14. Role of DPP-4 inhibitors in the management of type 2 diabetes
    Ramesh Ramesh, D. D. Gupta · 2018 · International Journal of Basic & Clinical Pharmacology
  15. Further Possible Mechanisms of Dipeptidyl Peptidase-4 Inhibitors to Decrease Blood Glucose in Subjects with Type 2 Diabetes
    Hiroyuki Koshiyama · 2011 · Japanese Clinical Medicine
  16. Cellular aging in cardiovascular diseases
    Hisko Oeseburg · 2010 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  17. L’optimisation de l’équilibre glycémique renforce l’effet insulinotrope des incrétines chez les diabétiques de type 2… ou la glucotoxicitérevisitée
    Patrice Darmon · 2009 · Diabetologia Notes de lecture
  18. Incretin secretion is not restored by short-term strict glycaemic control in Korean hyperglycaemic patients with type 2 diabetes
    Seung‐Hwan Lee, Ji-Hyun Kim, Jeong-Ah Shin, Eun Sook Kim, Jae‐Hyoung Cho, Seung‐Hyun Ko, Kun‐Ho Yoon, Yu‐Bae Ahn · 2011 · Diabetes Research and Clinical Practice
  19. Marine invertebrate and bacterial extract library screens for novel modulators of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
    Catherine E. Merchant · 2011 · cIRcle (University of British Columbia)
  20. Efeito da cirurgia bariátrica sobre parâmetros clínicos, laboratoriais e fatores de risco cardiovascular
    Fernanda Reis de Azevedo Rabello · 2016 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  21. The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell
    Gareth E. Lim · 2010 · TSpace (University of Toronto)
  22. Efeito da cirurgia bariátrica sobre parâmetros clínicos, laboratoriais e fatores de risco cardiovascular
    Programa de Cardiologia, São Paulo · 2016
  23. Acute Impaired Glucoregulation and Disrupted Gastrointestinal Hormone Secretion in Adolescents in Response to Caffeine-Containing and Nutritionally Fortified “Energy Shots”
    Heidi Virtanen · 2017 · Libraries and Cultural Resources (University of Calgary)
  24. Effects of Exercise on Incretin Hormones
    Saeed Reza Toghi-Eshghi · 2018 · ERA: Education and Research Archive (University of Alberta)
  25. PHOENIXIN-20 IN MICE: TISSUE DISTRIBUTION, IN VITRO ENDOCRINE ACTIONS AND IN VIVO EFFECTS ON FOOD INTAKE
    Kundanika Mukherjee · 2020 · HARVEST (University of Saskatchewan)
  26. Future Antidiabetic Drugs
    Emma Johns and, Miles Fisher · 2022
  27. Gut Peptide Agonism in the Treatment of Obesity and Diabetes
    Gerald Grandl, Aaron Novikoff, Richard D. DiMarchi, Matthias H. Tschoep, Timo D. Müller · 2020 · Comprehensive physiology
  28. Additional file 1 of Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes
    Karlijn A. C. Meeks, Amy R. Bentley, Themistocles L. Assimes, Franceschini, Nora, Adebowale Adeyemo, Rotimi, Charles N., Ayo Priscille Doumatey · 2023 · Figshare
  29. Pathogénie moléculaire de l'hyperplasie surrénalienne GIP-dépendante et du comportement invasif des adénomes hypophysaires
    Fanny Chasseloup · 2022 · theses.fr (ABES)
  30. Luseogliflozin restores GIP responsiveness in diabetic male mice with preserved β‐cell function
    Quan Yingyue, Harumi Takahashi, Norihide Yokoi, Wataru Ogawa, Kenji Sugawara · 2026 · Physiological Reports